Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study)
Figure 7
Kaplan-Meier curves for the time to the first adverse event caused by the anticholinergic agent (52 weeks).
